Skip to main content
Have a personal or library account? Click to login
Effect of occupational exposure to cytostatics and nucleotide excision repair polymorphism on chromosomal aberrations frequency Cover

Effect of occupational exposure to cytostatics and nucleotide excision repair polymorphism on chromosomal aberrations frequency

Open Access
|Jun 2009

References

  1. AHEM. (2007). Metody biologického monitorování genotoxických účinků faktorů prostředí. Cytogenetická analýza periferních lymfocytů. Aktualizácia platnej štandardnej metodiky. AHEM 1/2007, SZÚ, Praha, 30 pp.
  2. Angelini S, Kumar R, Carbone F, Bermejo JL, Maffei F, Cantelli-Forti G, Hemminki K and Hrelia P. (2008). Inherited susceptibility to bleomycin-induced micronuclei: correlating polymorphisms inand DNA repair genes with mutagen sensitivity.: 90-97.
  3. Burgaz S, Karahalil B, Canhi Z, Terzioglu F, Ancel G, Anzion RB, Bos RP and Hüttner E. (2002). Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations.: 129-135.
  4. Cavallo D, Ursini CL, Omodeo-Sale E and Iavicoli S. (2007). Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs.: 11-18.
  5. Cavallo D, Ursini LC, Perniconi B, Di Francesco A, Giglio M, Rubino FM, Marinaccio A and Iavicoli S. (2005). Evaluation of genotoxic effects induced exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees.: 45-51.
  6. Connor TH. (2006). Hazardous anticancer drugs in health care: environmental exposure assessment.: 615-623.
  7. Deng H, Hang M, He J, Wu W, Jin L, Zheng W, Lou J and Wang B. (2005). Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points.: 351-357.
  8. Fransman W, Huizer D, Tuerk J and Kromhout H. (2007a). Inhalation and dermal exposure to eight antineoplastic drugs in an industrial laundry facility.: 396-403.
  9. Fransman W, Roeleveld N, Peelen S, de Kort W, Kromhout H and Heederik D. (2007b). Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes.: 112-119.
  10. Fransman W, Vermeulen R and Kromhout H. (2005). Dermal exposure to cyclo-phosphamide in hospitals during preparation, nursing and cleaning activities.: 403-412.
  11. Hemminki K. (2001).Appendix I. In: WHO Library Cataloguing-in-Publication Data, Biomarkers in risk assessment: validity and validation (Environmental health criteria) 222, WHO, Geneva, 241pp, 47-94.
  12. Hou SM, Fält S, Angelini S, Yang K, Nyberg F, Lambert B and Hemminki K. (2002). Thevariant alleles are associated with increased aromatic DNA adduct level and lung cancer risk.: 599-603.
  13. Kumar R, Höglund L, Zhao CH, Försti A, Snellman E and Hemminki K. (2003). Single nucleotide polymorphisms in thegene: determination of role in DNA repair and breast cancer risk.: 671-675.
  14. Laczmanska I, Gil J, Karpinski P, Stembalska A, Trusewicz A, Pesz K, Ramsey D, Schlade-Bartusiak K, Blin N and Sasiadek MM. (2007). Polymorphism in nucleotide excision repair genecorrelates with bleomycin-induced chromosomal aberrations.: 666-671.
  15. Major J, Jakab MG and Tompa A. (1999). The frequency of induced premature centromere division in human populations occupationally exposed to genotoxic.: 241-249.
  16. Maluf SW and Erdtmann B. (2000). Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis.: 21-27.
  17. Mohrenweiser HW, Xi T, Vazquez-Matias J and Jones IM. (2002). Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans.: 1054-1064.
  18. Musak L, Vodicka P, Klimentová G, Soucek P, Hánová M, Mikulková R, Buchancová J, Vodicková L, Poláková V and Péc M. (2006). Chromosomal damage and polymorphisms of DNA repair genesandin workers exposed to cytostatics.(Suppl 2): 57-60.
  19. Norppa H. (2004). Cytogenetic biomarkers and genetic polymorphisms.: 309-334.
  20. Norppa H. (2003). Genetic susceptibility, biomarker responses, and cancer.: 339-348.
  21. Pilger A, Köhler I, Stettner H, Mader RM, Rizovski B, Terkola R, Diem E, Franz-Hainzl E, Konnaris CM Valic E and Rüdinger HW. (2000). Long-term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs.: 442-448.
  22. Rekhadevi PV, Sailaja N, Chandrasekhar M, Mahboob M, Rahman MF and Grover P. (2007). Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.: 395-401.
  23. Rombaldi F, Cassini C, Salvator M, Saffi J and Erdtmann B. (2009). Occupational risk assessment of genotoxicity and oxidative stress in workers handling antineoplastic drugs during a working week.: 143-148.
  24. Rubes J, Kucharová S, Vozdová M, Musilová P and Zudová Z. (1998). Cytogenetic analysis of peripheral lymphocytes in medical personnel by means of FISH.: 293-298.
  25. Skjelbred CF, Svendsen M, Haugan V, Eek AK, Clausen KO, Svendsen MV and Hansteen IL. (2006). Influence of DNA repair gene polymorphisms ofand the folate metabolism gene MTHFR on chromosomal aberration frequencies.: 151-162.
  26. Sudprasert W, Navasumrit P and Ruchirawat M. (2006). Effects of low-dose gamma radiation on DNA damage, chromosomal aberration and expression of repair genes in human blood cells.: 503-511.
  27. Testa A, Giachelia M, Palma S, Appolloni M, Padua L, Tranfo G, Spagnoli M, Tirindelli D and Cozzi R. (2007). Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms.: 46-55.
  28. Tuimala J, Szekely G, Gundy S, Hirvonen A and Norppa H. (2002). Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity.: 1003-1008.
  29. Tuimala J, Szekely G, Wikman H, Järventaus H, Hirvonen A, Gundy S and Norppa H. (2004). Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations.: 319-333. Erratum in2005,: 303.
  30. Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, Dusinska M, Kuricova M, Zamecnikova M, Musak L, Buchancova J, Norppa H, Hirvonen A, Vodickova L, Naccarati A, Matousu Z and Hemminki K. (2004). Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA.: 757-763.
  31. Vorlíček J, Vyzula R and Adam Z. (2000). Praktická onkologie, vybrané kapitoly. Grada Publishing s.r.o., Praha, pp.77-154.
  32. Wick U and Gebhart E. (2005). Studies on the action of mitomycin C and bleomycin on telomere lengths of human lymphocyte chromosomes.: 463-469.
DOI: https://doi.org/10.2478/v10102-009-0002-6 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 13 - 17
Published on: Jun 19, 2009
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2009 Ludovít Mušák, Veronika Poláková, Erika Halašová, Oto Osina, Ludmila Vodičková, Janka Buchancová, Henrieta Hudečková, Pavel Vodička, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.